Search - tctmd.com

Displaying 241 - 260 of 2263

Sort: Relevancy | Date

News Daily News

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

L.A. McKeown

February 06, 2024

Presentation Miami Valves 2024

Modern PCI: Achieve Optimal Treatment with AGENT DCB

Presenter: Yiannis S. Chatzizisis

February 03, 2024

Presentation Miami Valves 2024

AGENT™ Drug-Coated Balloon

Presenter: John M. Lasala

February 03, 2024

Presentation CTO 2024

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Presenter: Ajay J. Kirtane

February 03, 2024

Presentation CTO 2024

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Presenter: Carlos Campos

February 03, 2024

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

Presentation Miami Valves 2024

AGENT DCB Clinical Data

Presenter: Nicolas M. Van Mieghem

February 01, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

Experts Warn of Looming Private Equity Interest in Cardiology Care

Michael O'Riordan

January 15, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Daily News

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Michael O'Riordan

December 18, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

Presentation Cardiovascular Interventions 2023

Conversations in Cardiology Decisions Are Not Always Black and White

Presenter: Morton J. Kern

November 10, 2023

Presentation Cardiovascular Interventions 2023

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

Presenter: Ajay J. Kirtane

November 10, 2023

Presentation Cardiovascular Interventions 2023

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

Presenter: Paul S. Teirstein

November 10, 2023

Presentation Cardiovascular Interventions 2023

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Presenter: Ajay J. Kirtane

November 10, 2023

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

Advertisement

UK Cardiac Audit Reveals Some Good, Some ‘Appalling’ Trends in PCI

Modern PCI: Achieve Optimal Treatment with AGENT DCB

AGENT™ Drug-Coated Balloon

The Dawn of Drug Coated Balloons, In-stent Restenosis, and Beyond

Breaking Barriers in Bifurcation PCI With Low LVEF: DES + DCB With Pioneering Percutaneous Ventricular Assist Device

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

AGENT DCB Clinical Data

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Experts Warn of Looming Private Equity Interest in Cardiology Care

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Top Coronary Artery Disease News of 2023

To Close Equity Gaps With New PCI-Capable Hospitals, Location Matters

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Conversations in Cardiology Decisions Are Not Always Black and White

A (Heart Team) Discussion is Essential Prior to Complex High Risk PCI

The Heart Team is Overrated: Ad Hoc for Complex High Risk PCI is Reasonable in Some Pre- Consented Patients

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content